Evidence map›Paper›PMID 23226102›Full record

ArticleNeoplasia (New York, N.Y.)2012

Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNA.

Roberto Plebani, Gavin R Oliver, Marco Trerotola, Emanuela Guerra, Pamela Cantanelli, Luana Apicella, Andrew Emerson, Alessandro Albiero, Paul D Harkin, Richard D Kennedy and 1 more

Abstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Chimeric RNAiScience · 2023
    Article
  3. A non-mutatedFrontiers in oncology · 2023
    Article
  4. Pattern recognition in the landscape of seemingly random chimeric transcripts.Computational and structural biotechnology journal · 2023
    Article
  5. Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  6. Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma.Journal of clinical and experimental hematopathology : JCEH · 2021
    Article
  7. Article
  8. Pharmacogenetic and pharmacogenomic discovery strategies.Cancer drug resistance (Alhambra, Calif.) · 2019
    Review
  9. Article
  10. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.Journal of the National Cancer Institute · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roberto PlebaniUnit of Cancer Pathology, Centre of Excellence for Research on Aging, G. D'Annunzio University Foundation, Chieti, Italy.
Gavin R Oliver
Marco Trerotola
Emanuela Guerra
Pamela Cantanelli
Luana Apicella
Andrew Emerson
Alessandro Albiero
Paul D Harkin
Richard D Kennedy
Saverio Alberti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mRNA chimeras from chromosomal translocations often play a role as transforming oncogenes. However, cancer transcriptomes also contain mRNA chimeras that may play a role in tumor development, which arise as transcriptional or post-transcriptional events. To identify such chimeras, we developed a deterministic screening strategy for long-range sequence analysis. High-throughput, long-read sequencing was then performed on cDNA libraries from major tumor histotypes and corresponding normal tissues. These analyses led to the identification of 378 chimeras, with an unexpectedly high frequency of expression (≈2 x 10(-5) of all mRNA). Functional assays in breast and ovarian cancer cell lines showed that a large fraction of mRNA chimeras regulates cell replication. Strikingly, chimeras were shown to include both positive and negative regulators of cell growth, which functioned as such in a cell-type-specific manner. Replication-controlling chimeras were found to be expressed by most cancers from breast, ovary, colon, uterus, kidney, lung, and stomach, suggesting a widespread role in tumor development.

Indexed as

TranscriptomeBase SequenceCell Line, TumorCell ProliferationGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMolecular Sequence DataMutant Chimeric ProteinsNeoplasmsRNA, MessengerSequence AlignmentMutant Chimeric ProteinsRNA, Messenger

Identifiers

PMID23226102
PMCPMC3514740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.